Friday 6 November 2026
Export MCK’s income statement to Excel — free account
McKesson Corporation
MCK Healthcare Medical Distribution
McKesson Corporation’s revenue for fiscal 2026 (year ended March 2026) was $403.4 billion, up 12.4% from fiscal 2025.
- Revenue
- +7.57%
- EPS
- +17.0%
- Free cash flow
- +32.5%
- Total debt
- +7.08%
Quarter to September 2026, against a year earlier
1,061.69
10.31
−0.96%
Follow MCK
Alert me
| Sep '26 From the 10-Q filed 4 Nov | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
7 | 7 | 7 | 7 |
+8 more TTM periods Free account |
| (190.51%) | (168.45%) | (274.39%) | (240.78%) | ||
| 5.33% | 5.41% | 6.05% | 5.59% | ||
ROIC |
114.15% | 70.49% | 66.20% | 45.30% | |
Return on Tangible Assets |
(93.14%) | (94.97%) | (66.70%) | (74.83%) | |
Average Days of Receivables |
26.85 | 26.92 | 25.32 | 25.88 | |
Free Cash Flow per Share |
59.05 | 51.77 | 43.77 | 78.28 | |
Free Cash Flow |
6,868.00 | 6,145.00 | 5,410.00 | 9,644.00 | |
Capital Expenditures |
(635.00) | (708.00) | (745.00) | (838.00) | |
| Other line items | |||||
Cash ROIC |
41.08% | 38.20% | 39.16% | 70.30% | |
Accounts Receivable Turnover |
14.17 | 14.06 | 15.05 | 14.73 | |
Accounts Payable Turnover |
6.27 | 6.51 | 6.75 | 6.95 | |
Inventory Turnover |
14.85 | 15.43 | 16.48 | 15.08 | |
Average Days of Payables |
61.31 | 58.74 | 56.29 | 57.71 | |
Days of Inventory on Hand |
25.53 | 24.20 | 22.72 | 25.74 | |
Tax Rate |
(0.18) | (0.18) | (0.18) | (0.19) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
2.00% | 1.99% | 2.01% | 2.08% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
21.87 | 23.62 | 25.15 | 24.47 | |
Operating CF/Net income |
1.60 | 1.49 | 1.29 | 2.42 | |
Depreciation/Fixed assets |
0.29 | 0.29 | 0.27 | 0.26 | |
Capex/Depreciation |
(0.82) | (0.92) | (1.02) | (1.23) | |
Revenue per Share |
3,600.95 | 3,462.37 | 3,264.00 | 3,230.18 | |
Operating CF per Share |
64.51 | 57.73 | 49.80 | 85.08 | |
Capex per Share |
(5.46) | (5.96) | (6.03) | (6.80) | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates · fundamentals updated 4 Nov 2026